GR

Geeta Rani

Active Director Director DIN 08673889
DIN 08673889 First appointment Jan 2020 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2020
Shareholding value •••• Premium profile

About Geeta Rani

Data last updated:

Geeta Rani is a Director at Human Pain Care Private Limited (since 2020). The company operates in Healthcare. Human Pain Care Private Limited reported revenue of ₹3,269 (FY 2020).

DIN 08673889
Primary Designation Director
Industry Healthcare
First Appointment 21 Jan 2020
Oldest Company Age 6 yrs
Largest company Human Pain Care Private Limited · ₹3,269 (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Human Pain Care Private Limited U85193CH2020PTC042871
Director21 Jan 20202020₹3,269 (FY 2020)Active

Board colleagues of Geeta Rani

NameDINCompanyDesignation
Kamal Kumar Sawhney08673888Human Pain Care Private LimitedDirector

Directorship timeline

Open interactive timeline →
Human Pain Care Private Limited
Premium access

Shareholding and investment profile for Geeta Rani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Geeta Rani

Geeta Rani currently holds 1 directorship: Human Pain Care Private Limited (Director, since 21 Jan 2020, revenue ₹3,269 (FY 2020)).

Geeta Rani was first appointed on 21 Jan 2020 as Director at Human Pain Care Private Limited.

The current boards of Geeta Rani's companies include Kamal Kumar Sawhney (Human Pain Care Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available